This is a medicine used to treat tuberculosis, which is a serious lung infection caused by bacteria. It helps stop the bacteria from multiplying. It's sometimes called Tisamid.
Every report comes from a Lived member, sent anonymously.
Have you tried Pyrazinamide for Tuberculosis?
Pyrazinamide is an antibiotic used to treat active tuberculosis (TB), a bacterial infection that most often affects the lungs but can involve other parts of the body. It is never used on its own. In the standard six-month treatment for TB that responds to the usual drugs, pyrazinamide is taken with isoniazid and rifampin for the first two months, after which isoniazid and rifampin continue for four more months. It is also one of four drugs in a newer four-month option that the Centers for Disease Control and Prevention (CDC) lists for people 12 and older with drug-susceptible TB of the lungs, alongside rifapentine, moxifloxacin and isoniazid. For TB that resists some standard drugs, pyrazinamide is often part of a combination tailored to the person by the treating team. It is used for adults and children. A two-month course of rifampin plus pyrazinamide was once recommended in the United States for latent TB, the inactive form of infection that causes no symptoms, but it was linked to severe and sometimes fatal liver injury. In the US, pyrazinamide is sold as a generic tablet; the former brand Zinamide and the combination tablet Rifater are no longer marketed.
TB bacteria grow slowly, and some of them can survive treatment in a resting, barely active state. These leftover bacteria are the main reason TB can come back after treatment ends. Pyrazinamide is especially good at killing these slow or resting bacteria that other drugs can leave behind. It is a prodrug: an enzyme made by the TB bacterium itself converts it into pyrazinoic acid, the active form. Exactly how pyrazinoic acid kills the bacteria is still not fully understood. What is well established is its effect on treatment: adding pyrazinamide to the first two months is what allowed standard TB therapy to be shortened from nine months to six while keeping the chance of relapse low.
Pyrazinamide comes as a 500 mg tablet taken by mouth, with or without food. Most people take it once a day; some treatment programs use larger doses given twice a week instead. The dose is based on body weight and is adjusted if weight changes. Kidney or liver problems can make the drug stay in the body longer, which the prescriber takes into account. Every dose matters, and the whole course needs to be finished even after symptoms improve, because stopping early can let surviving bacteria cause the infection again. Many health departments support treatment with directly observed therapy, in which a health worker watches each dose being taken. If a dose is missed, follow the care team's instructions; do not take two doses together to make up for it. In the standard regimen, pyrazinamide itself is stopped after the first two months while the other drugs continue.
Nausea, loss of appetite and mild joint or muscle aches are common. Pyrazinamide also raises the level of uric acid in the blood in many people. This usually causes no symptoms, but it can trigger gout, a form of arthritis that causes sudden painful, swollen joints. Rash, itching and greater sensitivity to sunlight can also occur, so sun protection is sensible during treatment. The most important serious risk is liver injury (drug-induced hepatitis), which can develop at any point during treatment and is more likely at higher doses. Contact the prescriber right away for dark urine, yellowing of the skin or eyes, loss of appetite with nausea or vomiting, unusual tiredness or fever. Painful or swollen joints should also be reported promptly, since they can signal gout.
Pyrazinamide is not used in people with severe liver damage, during an attack of gout, or after an allergic reaction to it. An allergy to niacin (vitamin B3) or to ethionamide, another TB medicine, is also worth mentioning before starting. Existing liver disease, heavy alcohol use, a history of gout, kidney disease or diabetes call for closer monitoring. Alcohol adds to the risk of liver injury, so it is worth asking how much, if any, is safe during treatment. The prescriber and pharmacist should know about all other medicines and supplements, particularly any that can affect the liver. Pyrazinamide can make diabetes harder to manage and can cause misleading results on urine ketone test strips, so people who rely on them should ask about another type of ketone test. The label advises using pyrazinamide in pregnancy only when clearly needed, because its effects on a developing baby have not been well studied. Small amounts pass into breast milk. Anyone pregnant, planning pregnancy or breastfeeding should discuss the regimen with the TB care team.
Before starting, most people have blood tests of liver function and uric acid, and these are repeated at intervals during treatment and whenever symptoms suggest a problem. Follow-up visits, often coordinated with the local health department, track how the infection is responding and watch for side effects. A raised uric acid level on a blood test without symptoms, or mild joint aches, does not usually mean the drug must stop. If liver injury or gout develops, however, pyrazinamide is generally stopped and not restarted, and the care team builds the rest of the treatment around other drugs, which can mean a longer total course. For most people the time on pyrazinamide is limited to the early phase of treatment, while the full course continues for months afterward.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Pyrazinamide, what you've noticed, or ask the community a question.